Seelos Therapeutics Inc (SEELQ)

[Dimitrios George]

Unfortunately, we aren't being done any favors by institutions. As crazy as Irina's price target is, it is out there for the investment world to see and ponder. And we thought Feuerstein was bad. At least Irina is not attacking the efficacy of the drug. She is not persuaded by the size of the market and the ability of Vitaros to penetrate it.

I am with Norecoil on his observations. I think I will go see a fortune teller for investment advice.

A large or global partner for Vitaros plus a launch should help shore up the price.